Skip to content
10-Q

Quarterly Report

JINZANGHUANG TIBET PHARMACEUTICALS, INC.

0001096906-13-000805

← back to feed
Filed
May 15, 2013 12:00 AM ET
Period of report
—
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Filing index ↗

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2013 · May 6, 2013 50.67M sh
Operating Cash Flow Q3 2013 · Mar 31, 2013 $6.65M
Operating Cash Flow Q3 2013 · Mar 31, 2012 $4.57M
Stockholders Equity Q3 2013 · Mar 31, 2013 $16.48M
Stockholders Equity Q3 2013 · Jun 30, 2012 $8.99M
Total Liabilities Q3 2013 · Mar 31, 2013 $986.3K
Total Liabilities Q3 2013 · Jun 30, 2012 $632.3K
Current Assets Q3 2013 · Mar 31, 2013 $17.7M
Current Assets Q3 2013 · Jun 30, 2012 $9.5M
Total Assets Q3 2013 · Mar 31, 2013 $18.28M
Total Assets Q3 2013 · Jun 30, 2012 $10.09M
Sga Expense Q3 2013 · Mar 31, 2013 $105.78K
Sga Expense Q3 2013 · Mar 31, 2013 $267.37K
Sga Expense Q3 2013 · Mar 31, 2012 $128.48K
Sga Expense Q3 2013 · Mar 31, 2012 $315.64K
Net Income Q3 2013 · Mar 31, 2013 $2.33M
Net Income Q3 2013 · Mar 31, 2013 $6.36M
Net Income restated Q3 2013 · Mar 31, 2012 $1.35M
Net Income Q3 2013 · Mar 31, 2012 $4.41M
Operating Income Q3 2013 · Mar 31, 2013 $3.25M
Operating Income Q3 2013 · Mar 31, 2013 $8.91M
Operating Income Q3 2013 · Mar 31, 2012 $1.99M
Operating Income Q3 2013 · Mar 31, 2012 $6.07M
Gross Profit Q3 2013 · Mar 31, 2013 $3.35M
Gross Profit Q3 2013 · Mar 31, 2013 $9.17M
Gross Profit Q3 2013 · Mar 31, 2012 $2.12M
Gross Profit Q3 2013 · Mar 31, 2012 $6.39M
Cost Of Revenue Q3 2013 · Mar 31, 2013 $908.57K
Cost Of Revenue Q3 2013 · Mar 31, 2013 $2.47M
Cost Of Revenue Q3 2013 · Mar 31, 2012 $595K
Cost Of Revenue Q3 2013 · Mar 31, 2012 $1.55M
Revenue Q3 2013 · Mar 31, 2013 $4.26M
Revenue Q3 2013 · Mar 31, 2013 $11.64M
Revenue Q3 2013 · Mar 31, 2012 $2.71M
Revenue Q3 2013 · Mar 31, 2012 $7.94M